Literature DB >> 16314808

Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.

Naoki Mitsuhata, Ryuji Fujita, Seiichi Ito, Makoto Mannami, Kojima Keimei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16314808     DOI： 10.1097/01.tp.0000184275.81396.45

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Rituximab associated neutropenia: description of three cases and an insight into the underlying pathogenesis.

Authors:  Alina Weissmann-Brenner; Baruch Brenner; Inessa Belyaeva; Meir Lahav; Esther Rabizadeh
Journal:  Med Sci Monit       Date:  2011-11

Review 2.  A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature.

Authors:  Maria Elena Farrugia; John A Goodfellow
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 3.  Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians.

Authors:  Muhammad Abdul Mabood Khalil; Muhammad Ashhad Ullah Khalil; Taqi F Taufeeq Khan; Jackson Tan
Journal:  J Transplant       Date:  2018-08-01

Review 4.  Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Authors:  Gianluigi Zaza; Paola Tomei; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Toxins (Basel)       Date:  2014-02-28       Impact factor: 4.546

Review 5.  Latest insights on ABO-incompatible living-donor renal transplantation.

Authors:  Junji Uchida; Akihiro Kosoku; Toshihide Naganuma; Tomoaki Tanaka; Tatsuya Nakatani
Journal:  Int J Urol       Date:  2019-09-14       Impact factor: 3.369
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.